
UiPath (PATH) Stock Forecast & Price Target
UiPath (PATH) Analyst Ratings
Bulls say
UiPath is attractive fundamentally because it is evolving from an RPA vendor into the governed orchestration layer for enterprise AI, with Cartographer, Process Atlas, and Maestro aimed at solving the hardest bottleneck: turning fragmented process knowledge into a living “Map of Work” that can be executed, audited, and continuously improved. Its platform economics also look strong, with AI ARR above $250M, 90%+ of $1M+ ARR customers using at least one AI product, DBNRR above 120% in key cohorts, and land-and-expand motions showing 16-24x+ ARR expansion and 62x/36x growth in top customer tiers since 2017. Profitability and cash generation are improving as well, with a 30%+ long-term non-GAAP operating margin target, FY/26 non-GAAP margins at 23% versus 8% in FY/22, gross margin near 84%, and SBC expected to fall toward 8-10% of revenue, supporting a constructive long-term view.
Bears say
UiPath is facing a negative outlook because its ambitious shift from core RPA toward enterprise orchestration and agentic automation is still early, with investors lacking a clear long-term growth framework despite management’s intent to accelerate. Although AI ARR reached $250M in Q2 and the long-term operating margin target remains 30%+, growth execution has been hampered by leadership transition, strategy changes, elevated macro uncertainty, and elongated sales cycles. The business also depends heavily on partner integrations and a concentrated customer base, while competition from larger enterprise platforms and other automation vendors keeps the “right to win” uncertain and sentiment muted.
This aggregate rating is based on analysts' research of UiPath and is not a guaranteed prediction by Public.com or investment advice.
UiPath (PATH) Analyst Forecast & Price Prediction
Start investing in UiPath (PATH)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About UiPath (PATH) Forecast
UiPath (PATH) Analyst Forecast & Price Prediction
Start investing in UiPath (PATH)
Order type
Buy in
Order amount
Est. shares
0 shares